Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 61, Issue 25, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.202204052
Keywords
Fragments; Microtubule-Targeting Agents; Molecular Mechanism of Action; Rational Drug Design; Tubulin
Categories
Funding
- BioEM Lab of the Biozentrum, University of Basel, Switzerland
- Regione Lombardia [239047 NEON]
- Swiss National Science Foundation [31003A_166608, 310030_192566]
- ETH-Bereich Forschungsanstalten
- Swiss National Science Foundation (SNF) [310030_192566] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
This study developed an antitubulin small molecule, Todalam, through two rounds of chemical synthesis based on a crystallographic fragment screen. Todalam binds to a novel tubulin site, disrupts microtubule networks, induces cell death, and synergizes with vinblastine. It destabilizes microtubules by inhibiting the conformational switch in alpha-tubulin and sequestering tubulin dimers. This work demonstrates the importance of using tubulin-binding fragments for innovative antitubulin drug and chemical probe discovery campaigns.
In this study, we capitalized on our previously performed crystallographic fragment screen and developed the antitubulin small molecule Todalam with only two rounds of straightforward chemical synthesis. Todalam binds to a novel tubulin site, disrupts microtubule networks in cells, arrests cells in G2/M, induces cell death, and synergizes with vinblastine. The compound destabilizes microtubules by acting as a molecular plug that sterically inhibits the curved-to-straight conformational switch in the alpha-tubulin subunit, and by sequestering tubulin dimers into assembly incompetent oligomers. Our results describe for the first time the generation of a fully rationally designed small molecule tubulin inhibitor from a fragment, which displays a unique molecular mechanism of action. They thus demonstrate the usefulness of tubulin-binding fragments as valuable starting points for innovative antitubulin drug and chemical probe discovery campaigns.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available